Goldman Sachs’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-921
| Closed | -$28K | – | 5399 |
|
2022
Q3 | $28K | Sell |
921
-568
| -38% | -$17.3K | ﹤0.01% | 5111 |
|
2022
Q2 | $48K | Sell |
1,489
-7,097
| -83% | -$229K | ﹤0.01% | 5289 |
|
2022
Q1 | $830K | Buy |
8,586
+7,292
| +564% | +$705K | ﹤0.01% | 4247 |
|
2021
Q4 | $252K | Buy |
+1,294
| New | +$252K | ﹤0.01% | 4869 |
|
2021
Q3 | – | Sell |
-3,706
| Closed | -$1.47M | – | 5572 |
|
2021
Q2 | $1.47M | Buy |
+3,706
| New | +$1.47M | ﹤0.01% | 3749 |
|